DWTX
Dogwood Therapeutics, Inc.
1.40$
-0.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +39.8% | +1.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +261.6% | -24.9% | -89.7% | -23.6% | +363.5% | -70.3% | +5,222.8% | +88.0% | -7.7% | -1.4% | -5.1% | -13.1% | -32.6% | -21.6% | -60.9% | +12.1% | -32.9% | -20.3% | +15.2% | -2.2% | +59.2% | +332.8% | +5.2% | +5.5% | +465.0% | -83.9% | +14.2% | +21.6% | – | |
| – | -11.4% | -21.2% | +30.1% | +46.3% | +396.0% | +150.1% | -78.9% | -20.4% | +7.0% | +10.3% | -6.1% | +6.2% | -23.4% | -15.7% | +29.5% | -13.2% | -2.1% | -6.7% | +15.5% | -24.4% | +140.7% | +195.9% | -61.9% | -32.1% | -4.8% | +14.0% | +63.9% | -33.0% | – | |
| – | +48.4% | -23.2% | -32.4% | +40.7% | +394.6% | +141.2% | -52.4% | +40.1% | -4.0% | +1.9% | -5.4% | -7.3% | -29.4% | -19.4% | -25.5% | -5.1% | -13.7% | -10.7% | +15.5% | -18.6% | +115.1% | +227.8% | -41.3% | -11.4% | +303.0% | -75.9% | +33.4% | -4.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.2% | -3.5% | +15.3% | +38.3% | -10.1% | -23.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.9% | -1,063.8% | – | -103.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.